Management of regional metastatic disease in cutaneous malignancy of the head and neck. 3. Merkel cell carcinoma

C M Bowe; B Gurney; S Whitaker; C Newlands

doi:10.1016/j.bjoms.2019.08.022

Management of regional metastatic disease in cutaneous malignancy of the head and neck. 3. Merkel cell carcinoma

Br J Oral Maxillofac Surg. 2019 Nov;57(9):847-856. doi: 10.1016/j.bjoms.2019.08.022. Epub 2019 Oct 12.

Authors

C M Bowe¹, B Gurney², S Whitaker³, C Newlands²

Affiliations

¹ Department of Oral and Maxillofacial Surgery, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK. Electronic address: conor.bowe@nhs.net.
² Department of Oral and Maxillofacial Surgery, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK.
³ Department of Clinical Oncology, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK.

PMID: 31615708
DOI: 10.1016/j.bjoms.2019.08.022

Abstract

This is the third of three articles that give an overview of the current evidence for management of the neck and parotid in patients with cutaneous cancers of the head and neck. In this paper we discuss Merkel cell carcinoma (MCC) and review the latest evidence for management of the regional nodes.

Keywords: Merkel cell carcinoma; lymphatic metastasis; neck dissection; sentinel node biopsy.

Publication types

Review

MeSH terms

Carcinoma, Merkel Cell* / therapy
Head and Neck Neoplasms / therapy
Humans
Lymph Nodes
Lymphatic Metastasis
Neoplasm Staging
Sentinel Lymph Node Biopsy
Skin Neoplasms* / therapy